文献速递前列腺增生与排尿功能障碍

前列腺动脉栓塞术治疗良性前列腺增生的安全性与可行性:P-EASY研究

Prostate artery Embolisation Assessment of Safety and feasibilitY (P-EASY): a potential alternative to long-term medical therapy for benign prostate hyperplasia.
PubMed 文献 · BJU Int · 2018-08-27

P-EASY研究纳入51例前列腺体积>40 mL、中重度下尿路症状且药物失败或拒绝手术的BPH患者,行前列腺动脉栓塞术(PAE)并随访3个月。所有手术技术成功,无严重不良事件;非留置导尿患者IPSS和QoL分别平均降低18.8分(80.7%)和3.8分(80.6%)(P<0.001)。PAE短期安全有效,可能成为长期药物治疗的替代选择。

要点

  • PAE治疗BPH技术成功率高且无严重不良事件。
  • 非留置导尿患者IPSS和QoL改善率达95.1%。
  • 多数药物治疗患者可完全停用药物。

核心结论

  • PAE技术可行且安全,短期疗效优异,患者满意度高,可能替代BPH长期药物治疗。

研究设计与样本

  • 前瞻性单臂研究,纳入51例前列腺体积>40 mL、中重度下尿路症状、药物失败或拒绝手术的BPH患者,行PAE并随访3个月。

主要发现

  • 无严重不良事件,所有手术技术成功。
  • 非留置导尿患者IPSS和QoL改善率95.1%(P<0.001)。
  • IPSS平均降低18.8分(80.7%)(P<0.001),QoL平均降低3.8分(80.6%)(P<0.001)。
  • 30例药物治疗的非留置导尿患者中,23例完全停用所有药物,其余除1例外IPSS和QoL均显著改善。

临床怎么用

  • 对于药物失败或拒绝手术的BPH患者,PAE可作为短期改善症状和停用药物的微创选择。

局限性

  • 样本量较小(51例),随访仅3个月,缺乏长期疗效和对照比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the safety, short-term efficacy and early functional results of prostate artery embolisation (PAE), an emerging minimally invasive treatment for symptomatic benign prostate hyperplasia (BPH). PATIENTS AND METHODS: In all, 51 men with BPH (prostate size >40 mL) causing moderate-severe lower urinary tract symptoms, who had either failed or ceased medical therapy and had declined or were considered unsuitable for surgical intervention, were recruited to this study. All men underwent baseline clinical assessment, PAE, and 3-month follow-up. The primary endpoints of this study were safety and feasibility. Safety was measured by the incidence of post-PAE adverse events and feasibility was defined by technical success. Secondary endpoints were changes in the International Prostate Symptom Score (IPSS) and quality of life (QoL) score at 3 months after PAE. RESULTS: There were no serious adverse events and all procedures were technically successful. For non-catheterised patients, improvement in IPSS and QoL was reported in 95.1% of cases (P < 0.001). The mean reductions in IPSS and QoL were 18.8 points (80.7%) (P < 0.001) and 3.8 points (80.6%) (P < 0.001), respectively. Of the 30 non-indwelling-catheter-dependent men on medical therapy, 23 men were able to completely cease all medications, with all but one of the remaining men reporting significant improvements in IPSS and QoL score. CONCLUSION: PAE is a technically feasible and safe procedure, with excellent short-term efficacy. High rates of patient satisfaction were achieved in this study, along with significant reductions in prostate symptoms and improvements in QoL. PAE may be an alternative to long-term use of medical therapy for symptoms due to BPH.

来源:BJU Int,查看原文。版权归原作者所有。

引用

  1. Brown N, Walker D, McBean R, et al. Prostate artery Embolisation Assessment of Safety and feasibilitY (P-EASY): a potential alternative to long-term medical therapy for benign prostate hyperplasia. BJU Int. 2018. PMID: 30076682. doi:10.1111/bju.14504

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。